Regenerative medicine aims to develop methods to regrow, repair or replace damaged or diseased cells, organs or tissues. This involves therapy treatments using stem cells or tissue engineering techniques.

We understand that transitioning from research to clinical applications requires consistent, robust and scalable procedures. AMSBIO provides a range of cell products which cover from sourcing your starting cell material, growing and storing cell lines, differentiating to specialized cell types and GMP-compliant manufacturing. To find out more visit our expanded stem cell synergy page.

Gene Therapy covers both research and clinical development of novel therapeutic techniques based on a genetic engineering approaches. From identifying novel genetic targets that cause disease through to clinical studies testing the efficiency of therapeutic methods, we offer high quality products and services to support you. This includes gene delivery methods and CRISPR reagents to enable gene editing.

• Viral delivery systems - Lentivirus, Adenovirus, AAV
• Transfection reagents
• CRISPR reagents

Genetically engineered iPSCs enable cell therapy research with improved fidelity over cell lines and biochemical assays. This also provides an ideal model system for drug discovery with high throughput and reduced cost compared to animal model systems. Our ready-to-use genetically engineered cell lines reduce the time and materials needed for gene editing to allow human disease modelling for the development of therapies.

• Cas9-expressing iPSCs
• StemBright^™ Reporter iPSCs
• Knockout iPSCs